“…The number of hospital admissions for cardiovascular diseases (6.6, 10.6, and 8.3 per 10 5 cases), premature deaths for respiratory diseases (4.7, 5.4, and 4.9 per 10 5 cases), and long-term premature deaths for respiratory diseases (1.7, 2.6, and 2.2 per 10 5 cases) due to O 3 exposure above 5 ppb were obtained in 2019, 2020, and 2021, respectively ( Table S1 ). HA-CVD, MRD, and LT-MRD increased by 60.6%, 14.8%, and 52.9% per 10 5 cases in 2020, due to higher O 3 exposure ( Schwarz et al, 2021 ) and then decreased by 21.0%, 8.9%, and 15.4% per 10 5 cases in 2021 when annual mean of O 3 levels was reduced. In China, the authors observed a positive relationship between increase in O 3 levels and the risk of premature mortality, especial between exposure to O 3 and the risk of respiratory diseases and mortality ( Liu et al, 2017 ).…”